Patient preference and sensory perception of three intranasal corticosteroids for allergic rhinitis

Clinical Drug Investigation

Volumn 23, Issue 1, 2003, Pages 39-44

  Bunnag, Chaweewan ^a   Suprihati, Dr ^b   Wang, De Yun ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b DIPONEGORO UNIVERSITY   (Indonesia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE; MOMETASONE FUROATE; NOSE SPRAY; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DELIVERY SYSTEM; DRUG PREFERENCE; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTICENTER STUDY; PATIENT COMPLIANCE; PERCEPTION; PERENNIAL RHINITIS; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SMELLING;

EID: 0037250995     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200323010-00005     Document Type: Article

References (14)

1. Van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis: European Academy of Allergology and Clinical Immunology. Allergy 2000 Feb; 55 (2): 116-34
2. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001 Nov; 108 (5 Suppl.): S147-334
3. Wang DY, Niti M, Smith JD, et al. Rhinitis: do diagnostic criteria affect the prevalence and treatment? Allergy 2002; 57: 150-4
4. Bachert C, El Akkad T. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis. Ann Allergy Asthma Immunol 2002; 89: 292-7
5. Di Lorenzo G, Gervasi F, Drago A, et al. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitis. Clin Exp Allergy 1999 Oct; 29 (10): 1367-77
6. Ortolani C, Foresi A, Di Lorenzo G, et al. A double blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. FLNCO2 Italian Study Group. Allergy 1999 Nov; 54 (11): 1173-80
7. Smith JA, Schenkel EJ, Gross G, et al. Efficacy and safety of once-daily triamcinolone acetonide aqueous nasal spray in pediatric patients with spring grass seasonal allergic rhinitis [abstract 68]. In: 52nd Annual meeting of the American Academy of Allergy, Asthma and Immunology: 1996 New Orleans. J Allergy Clin Immunol 1996; 97 (1 pt 3): 197
8. Davies RJ, Nelson HS. Once daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis. Clin Ther 1997 Jan-Feb; 19 (1): 27-38
9. Mandl M, Nolop K, Lutsky BN. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis: 194-079 Study Group. Ann Allergy Asthma Immunol 1997 Oct; 79 (4): 370-8
10. Munk ZM, LaForce C, Furst JA, et al. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1996 Oct; 77 (4): 277-81
11. Small P, Houle PA, Day JH, et al. A comparison of triamcinolone acetonide nasal aerosol spray and fluticasone propionate aqueous solution spray in the treatment of spring allergic rhinitis. J Allergy Clin Immunol 1997 Nov; 100 (5): 592-5
12. Berridge MS, Heald DL, Muswick GJ, et al. Biodistribution and kinetics of nasal carbon-1 l-triamcinolone acetonide. J Nucl Med 1998 Nov; 39 (11): 1972-7
13. Kaliner MA. Physician prescribing practices: the role of patient preference with the selection of nasal steroids. Allergy Asthma Proc 2000 Nov-Dec; 22 (6 Suppl 1): S17-22
14. Fishken D. Patient preference and sensory comparisons of Nasacort AQ, Beconase AQ and Flonase [abstract P206]. In: Annual meeting of the American College of Allergy, Asthma and Immunology: Nov 1996 Boston. Ann Allergy Asthma Immunol 1996; 78: 154